Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Differential chemosensitivity in oncogene-transformed cells

T Hiwasa1, H Tokita, Y Ike

  • 1Division of Biochemistry, Chiba Cancer Center Research Institute, Japan.

Journal of Experimental Therapeutics & Oncology
|May 1, 1996
PubMed
Summary

Certain anticancer drugs effectively inhibit the growth of cancer cells, particularly those transformed by oncogenes like ras. These findings suggest potential chemotherapy applications for ras-induced cancers.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Adenovirus-mediated FIR demonstrated TP53-independent cell-killing effect and enhanced antitumor activity of carbon-ion beams.

Gene therapy·2015
Same author

Ras inhibitors.

Oncology reports·2011
Same author

Growth-suppressive activities of serine protease inhibitors, FOY-305, ONO-3403 and FO-349 toward human carcinoma cells.

Oncology reports·2011
Same author

Nucleotide-sequence of a canine oral papillomavirus containing a long noncoding region.

International journal of oncology·2011
Same author

Screening of peptides which suppress the proliferation of transformed cells.

International journal of oncology·2011
Same author

Enhancement of anti-proliferative activities of 5-FU, HCFU, SN-38, THP and ACNU by a serine protease inhibitor, FOY-305.

International journal of oncology·2011

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Anticancer drug efficacy varies significantly based on cellular transformation.
  • Oncogene-induced cellular transformation presents unique vulnerabilities to certain chemotherapeutic agents.

Purpose of the Study:

  • To evaluate the differential effects of various anticancer drugs on normal versus transformed cell lines.
  • To identify specific anticancer drugs effective against ras-oncogene-transformed cells for targeted cancer therapy.

Main Methods:

  • Utilized MTT colorimetric assays to assess cell viability and growth inhibition.
  • Employed cultured mouse and rat cells transformed by oncogenes and tumor viruses.

Main Results:

Related Experiment Videos

  • Aclarubicin, mitomycin C, and 1-hexylcarbamoyl-5-fluorouracil demonstrated superior growth inhibition in transformed cells compared to normal cells.
  • Nimustine, bleomycin, and 5-fluorouracil exhibited selective growth suppression in most transformed cell lines.
  • Ras-oncogene-transformed cells showed heightened sensitivity to 5-fluorouracil and 1-hexylcarbamoyl-5-fluorouracil.

    • Conclusions:

    • The evaluated drugs, particularly 5-fluorouracil and 1-hexylcarbamoyl-5-fluorouracil, show promise for treating ras-induced cancers.
    • Differential drug sensitivity in transformed cells supports the development of targeted chemotherapy strategies.